These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 17936506

  • 1. The normal equilibrium between CSF and plasma amyloid beta levels is disrupted in Alzheimer's disease.
    Giedraitis V, Sundelöf J, Irizarry MC, Gårevik N, Hyman BT, Wahlund LO, Ingelsson M, Lannfelt L.
    Neurosci Lett; 2007 Nov 12; 427(3):127-31. PubMed ID: 17936506
    [Abstract] [Full Text] [Related]

  • 2. Plasma and cerebrospinal fluid levels of amyloid beta proteins 1-40 and 1-42 in Alzheimer disease.
    Mehta PD, Pirttilä T, Mehta SP, Sersen EA, Aisen PS, Wisniewski HM.
    Arch Neurol; 2000 Jan 12; 57(1):100-5. PubMed ID: 10634455
    [Abstract] [Full Text] [Related]

  • 3. Analysis of Cerebrospinal Fluid, Plasma β-Amyloid Biomarkers, and Cognition from a 2-Year Phase 2 Trial Evaluating Oral ALZ-801/Valiltramiprosate in APOE4 Carriers with Early Alzheimer's Disease Using Quantitative Systems Pharmacology Model.
    Hey JA, Yu JY, Abushakra S, Schaefer JF, Power A, Kesslak P, Tolar M.
    Drugs; 2024 Jul 12; 84(7):825-839. PubMed ID: 38902572
    [Abstract] [Full Text] [Related]

  • 4. Elevation of the Plasma Aβ40/Aβ42 Ratio as a Diagnostic Marker of Sporadic Early-Onset Alzheimer's Disease.
    Kim HJ, Park KW, Kim TE, Im JY, Shin HS, Kim S, Lee DH, Ye BS, Kim JH, Kim EJ, Park KH, Han HJ, Jeong JH, Choi SH, Park SA.
    J Alzheimers Dis; 2015 Jul 12; 48(4):1043-50. PubMed ID: 26444752
    [Abstract] [Full Text] [Related]

  • 5. Oligomeric forms of amyloid-β protein in plasma as a potential blood-based biomarker for Alzheimer's disease.
    Wang MJ, Yi S, Han JY, Park SY, Jang JW, Chun IK, Kim SE, Lee BS, Kim GJ, Yu JS, Lim K, Kang SM, Park YH, Youn YC, An SSA, Kim S.
    Alzheimers Res Ther; 2017 Dec 15; 9(1):98. PubMed ID: 29246249
    [Abstract] [Full Text] [Related]

  • 6. The relationship of plasma Aβ levels to dementia in aging individuals with mild cognitive impairment.
    Fei M, Jianghua W, Rujuan M, Wei Z, Qian W.
    J Neurol Sci; 2011 Jun 15; 305(1-2):92-6. PubMed ID: 21440911
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Plasma β-amyloid in Alzheimer's disease and vascular disease.
    Janelidze S, Stomrud E, Palmqvist S, Zetterberg H, van Westen D, Jeromin A, Song L, Hanlon D, Tan Hehir CA, Baker D, Blennow K, Hansson O.
    Sci Rep; 2016 May 31; 6():26801. PubMed ID: 27241045
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Distinction between mild cognitive impairment and Alzheimer's disease by CSF amyloid β40 and β42, and protein-conjugated acrolein.
    Mizoi M, Yoshida M, Saiki R, Waragai M, Uemura K, Akatsu H, Kashiwagi K, Igarashi K.
    Clin Chim Acta; 2014 Mar 20; 430():150-5. PubMed ID: 24508996
    [Abstract] [Full Text] [Related]

  • 18. Impaired lipoprotein receptor-mediated peripheral binding of plasma amyloid-β is an early biomarker for mild cognitive impairment preceding Alzheimer's disease.
    Sagare AP, Deane R, Zetterberg H, Wallin A, Blennow K, Zlokovic BV.
    J Alzheimers Dis; 2011 Mar 20; 24(1):25-34. PubMed ID: 21157031
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. CSF biomarkers for Alzheimer disease correlate with cortical brain biopsy findings.
    Seppälä TT, Nerg O, Koivisto AM, Rummukainen J, Puli L, Zetterberg H, Pyykkö OT, Helisalmi S, Alafuzoff I, Hiltunen M, Jääskeläinen JE, Rinne J, Soininen H, Leinonen V, Herukka SK.
    Neurology; 2012 May 15; 78(20):1568-75. PubMed ID: 22517093
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.